Verastem Inc (VSTM)
$1.13
0.00 (0.00%)
VSTM Stock Quote Delayed 15 Minutes
Previous Close
$1.13
Market Cap
74.86M
PE Ratio
-0.62
EPS
-1.82
Volume (Avg. Vol.)
Day's Range
1.13 - 1.13
52-Week Range
1.04 - 6.33
Dividend & Yield
N/A (N/A)
VSTM Stock Predictions, Articles, and Verastem Inc News
10 Biotechnology Stocks to Sell Now
The overall ratings of 10 biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
10 Biotechnology Stocks to Sell Now
This week, the ratings of 10 biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
10 Biotechnology Stocks to Sell Now
This week, the ratings of 10 biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
10 Biotechnology Stocks to Sell Now
This week, the overall grades of 10 biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
12 Biotechnology Stocks to Sell Now
This week, the overall grades of 12 biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
10 Biotechnology Stocks to Sell Now
This week, the overall grades of 10 biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
11 Biotechnology Stocks to Sell Now
This week, the overall grades of 11 biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
10 Biotechnology Stocks to Sell Now
The overall ratings of 10 biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
10 Biotechnology Stocks to Sell Now
The overall ratings of 10 biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
11 Biotechnology Stocks to Sell Now
This week, the ratings of 11 biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
10 Biotechnology Stocks to Sell Now
This week, the ratings of 10 biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
10 Biotechnology Stocks to Sell Now
This week, the ratings of 10 biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
9 Biotechnology Stocks to Sell Now
This week, the ratings of nine biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
9 Biotechnology Stocks to Sell Now
This week, the overall grades of nine biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
9 Biotechnology Stocks to Sell Now
For the current week, the overall ratings of nine biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
7 Biotechnology Stocks to Sell Now
The ratings of seven biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
12 Biotech Stocks to Watch in 2015
These 12 small-cap stocks are set to have some of the most exciting years in the biotech sector. Be sure to watch these biotech stocks as they transform.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
F
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
